Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Umang Swami

Showing results (61-70 of 170) with videos related to

Pageof 17
Sort By:
Therapeutic Advances in Medical Oncology|March 26, 2026
Antibody-drug conjugates in prostate cancer: current landscape and future directionsZeynep Irem Ozay, Chadi Hage Chehade, Georges Gebrael, et al.
Critical Reviews in Oncology/Hematology|December 21, 2023
Predictors of response to neoadjuvant therapy in urothelial cancerNishita Tripathi, Gliceida Galarza Fortuna, Georges Gebrael, et al.
Cancers|February 22, 2018
A Phase I/II Study Targeting Angiogenesis Using Bevacizumab Combined with Chemotherapy and a Histone Deacetylase Inhibitor (Valproic Acid) in Advanced SarcomasVarun Monga, Umang Swami, Munir Tanas, et al.
Pituitary|July 22, 2019
Ipilimumab-induced hypophysitis, a single academic center experienceTravis Snyders, Daniel Chakos, Umang Swami, et al.
The Prostate|February 10, 2026
Corticosteroid Use and Risk of Adverse Events in Metastatic Hormone-Sensitive Prostate CancerUmang Swami, Qiujun Shao, Tamuno Alfred, et al.
Antibiotics (Basel, Switzerland)|October 30, 2020
Multivariable Analysis of 169 Cases of Advanced Cutaneous Melanoma to Evaluate Antibiotic Exposure as Predictor of Survival to Anti-PD-1 Based ImmunotherapiesUmang Swami, Adithya Chennamadhavuni, Nicholas Borcherding, et al.
Clinical Genitourinary Cancer|May 29, 2023
Treatment Patterns, Clinical Outcomes, Health Care Resource Utilization and Costs in Older Patients With Metastatic Castration-Resistant Prostate Cancer in the United States: An Analysis of SEER-Medicare DataUmang Swami, Himani Aggarwal, Mo Zhou, et al.
Cancer Chemotherapy and Pharmacology|June 14, 2019
A phase 1b, multicenter, open-label, dose-finding study of eribulin in combination with carboplatin in advanced solid tumors and non-small cell lung cancerSanjay Goel, Umang Swami, Kirushna Kumar, et al.
The Prostate|August 20, 2024
Real-world prevalence of adverse events with first-line systemic therapies among patients with metastatic castration-sensitive prostate cancerUmang Swami, Bin Xie, Christopher Young, et al.
Clinical Genitourinary Cancer|June 3, 2026
Impact of Prior Treatments on Clinical Outcomes in Patients With Metastatic Castration-Resistant Prostate Cancer: A Real-World Analysis in the United StatesUmang Swami, Neeraj Agarwal, Allison Thompson, et al.
Pageof 17

Showing results (61-70 of 170) with videos related to

Sort By:
Pageof 17
Therapeutic Advances in Medical Oncology|March 26, 2026
Antibody-drug conjugates in prostate cancer: current landscape and future directionsZeynep Irem Ozay, Chadi Hage Chehade, Georges Gebrael, et al.
Critical Reviews in Oncology/Hematology|December 21, 2023
Predictors of response to neoadjuvant therapy in urothelial cancerNishita Tripathi, Gliceida Galarza Fortuna, Georges Gebrael, et al.
Cancers|February 22, 2018
A Phase I/II Study Targeting Angiogenesis Using Bevacizumab Combined with Chemotherapy and a Histone Deacetylase Inhibitor (Valproic Acid) in Advanced SarcomasVarun Monga, Umang Swami, Munir Tanas, et al.
Pituitary|July 22, 2019
Ipilimumab-induced hypophysitis, a single academic center experienceTravis Snyders, Daniel Chakos, Umang Swami, et al.
The Prostate|February 10, 2026
Corticosteroid Use and Risk of Adverse Events in Metastatic Hormone-Sensitive Prostate CancerUmang Swami, Qiujun Shao, Tamuno Alfred, et al.
Antibiotics (Basel, Switzerland)|October 30, 2020
Multivariable Analysis of 169 Cases of Advanced Cutaneous Melanoma to Evaluate Antibiotic Exposure as Predictor of Survival to Anti-PD-1 Based ImmunotherapiesUmang Swami, Adithya Chennamadhavuni, Nicholas Borcherding, et al.
Clinical Genitourinary Cancer|May 29, 2023
Treatment Patterns, Clinical Outcomes, Health Care Resource Utilization and Costs in Older Patients With Metastatic Castration-Resistant Prostate Cancer in the United States: An Analysis of SEER-Medicare DataUmang Swami, Himani Aggarwal, Mo Zhou, et al.
Cancer Chemotherapy and Pharmacology|June 14, 2019
A phase 1b, multicenter, open-label, dose-finding study of eribulin in combination with carboplatin in advanced solid tumors and non-small cell lung cancerSanjay Goel, Umang Swami, Kirushna Kumar, et al.
The Prostate|August 20, 2024
Real-world prevalence of adverse events with first-line systemic therapies among patients with metastatic castration-sensitive prostate cancerUmang Swami, Bin Xie, Christopher Young, et al.
Clinical Genitourinary Cancer|June 3, 2026
Impact of Prior Treatments on Clinical Outcomes in Patients With Metastatic Castration-Resistant Prostate Cancer: A Real-World Analysis in the United StatesUmang Swami, Neeraj Agarwal, Allison Thompson, et al.
Pageof 17